Cognitive Behavioral Therapy for Chronic Pelvic Pain Syndrome
(EPPIC Trial)
Trial Summary
What is the purpose of this trial?
This trial tests a brief cognitive behavioral therapy to help people with chronic pelvic pain. It aims to teach skills for managing pain and symptoms with minimal clinician help. The study focuses on adults with conditions like interstitial cystitis and chronic prostatitis, which are hard to treat with current methods. The therapy works by changing how patients think about and cope with their pain. Cognitive Behavioral Therapy (CBT) has been shown to be an effective treatment for chronic pain in numerous studies.
Do I need to stop my current medications to join the trial?
You don't have to stop your current medications, but you should not start any new ones until after the initial 2-week pre-treatment baseline period, unless it's medically necessary.
What data supports the effectiveness of the treatment Minimal Contact-Cognitive Behavior Therapy for chronic pelvic pain syndrome?
Research suggests that psychological therapies, including cognitive behavioral therapy (CBT), can reduce pain in women with chronic pelvic pain when compared to no treatment, although the evidence is not conclusive. Additionally, multidisciplinary approaches that combine psychological and physical therapies show promise in managing chronic pelvic pain.12345
Is Cognitive Behavioral Therapy safe for humans?
How is Minimal Contact-Cognitive Behavior Therapy (MC-CBT) different from other treatments for chronic pelvic pain syndrome?
Minimal Contact-Cognitive Behavior Therapy (MC-CBT) is unique because it focuses on changing negative thought patterns and behaviors related to pain, and it can be delivered remotely, making it more accessible to people in rural or underserved areas. Unlike some other treatments, it does not rely on medication and can be adapted to fit into primary care settings, offering a flexible and cost-effective option for managing chronic pain.1011121314
Research Team
Jeffrey Lackner, PsyD
Principal Investigator
University at Buffalo (SUNY)
Eligibility Criteria
The EPPIC study is for adults aged 18-70 with a doctor-confirmed diagnosis of chronic pelvic pain syndromes like interstitial cystitis or chronic prostatitis. Participants must have had pelvic pain for at least six months, be willing to attend therapy sessions, and not start new medications during the initial study period.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 4-session cognitive behavioral therapy or education/support control over a 10-week acute phase
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Minimal Contact-Cognitive Behavior Therapy (Cognitive Behavioral Therapy)
- Patient Education/Support (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
Dr. Jonathan Slonin
State University of New York at Buffalo
Chief Medical Officer since 2020
MD from University of Miami, MBA from George Washington University
Stacy Knapper
State University of New York at Buffalo
Chief Executive Officer since 2023
BSEE from University of Puerto Rico-Mayagüez, MS in Management from Rensselaer Polytechnic Institute
University of Michigan
Collaborator
Marschall S. Runge
University of Michigan
Chief Executive Officer since 2015
MD, PhD
Karen McConnell
University of Michigan
Chief Medical Officer since 2020
MD
University of California, Los Angeles
Collaborator
Dr. Thomas Rando
University of California, Los Angeles
Chief Medical Officer since 2023
MD from UCLA
Amir Naiberg
University of California, Los Angeles
Chief Executive Officer since 2024
JD from UCLA